On the "Perverse Rebate System" in the Drug Market

An 'audiocast' that flips the script on the ideas of innovation and strategy in the largest and most lucrative market on Earth. When it comes to solving the mad riddle of how to "fix" the American Way of Healthcare, the simple message is this: You can't. It's time to go full bore against the grain. (These podcasts summarize the writing -- journal articles, market commentaries,, blog posts, white papers, executive briefing notes -- by John G. Singer and first published on the website of Blue Spoon Consulting (<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.bluespoonconsulting.com">https://www.bluespoonconsulting.com</a>).

Business

Management

An 'audiocast' that flips the script on the ideas of innovation and strategy in the largest and most lucrative market on Earth. When it comes to solving the mad riddle of how to "fix" the American Way of Healthcare, the simple message is this: You can't. It's time to go full bore against the grain. (These podcasts summarize the writing -- journal articles, market commentaries,, blog posts, white papers, executive briefing notes -- by John G. Singer and first published on the website of Blue Spoon Consulting (https://www.bluespoonconsulting.com).

An 'audiocast' that flips the script on the ideas of innovation and strategy in the largest and most lucrative market on Earth. When it comes to solving the mad riddle of how to "fix" the American Way of Healthcare, the simple message is this: You can't. It's time to go full bore against the grain. (These podcasts summarize the writing -- journal articles, market commentaries,, blog posts, white papers, executive briefing notes -- by John G. Singer and first published on the website of Blue Spoon Consulting (<a href="https://www.bluespoonconsulting.com" rel="noopener noreferrer">https://www.bluespoonconsulting.com</a>).

Share On the "Perverse Rebate System" in the Drug Market

Sign up to save your podcasts

On the "Perverse Rebate System" in the Drug Market

On the "Perverse Rebate System" in the Drug Market